🇺🇸 FDA
Pipeline program

Decitabine

DLAAG

Phase 2 small_molecule active

Quick answer

Decitabine for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Shanghai Tong Ren Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai Tong Ren Hospital
Indication
Acute Myeloid Leukemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials